Consolidated Statement Of Cash Flows

TAKARA BIO INC. - Filing #7300711

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
5,063,000,000 JPY
2,560,000,000 JPY
Interest and dividends received
151,000,000 JPY
89,000,000 JPY
Interest paid
-10,000,000 JPY
-11,000,000 JPY
Net cash provided by (used in) operating activities
6,099,000,000 JPY
2,087,000,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-396,000,000 JPY
-10,805,000,000 JPY
Other, net
0 JPY
-2,000,000 JPY
Cash flows from financing activities
Dividends paid
-2,046,000,000 JPY
-5,047,000,000 JPY
Net cash provided by (used in) financing activities
-2,151,000,000 JPY
-5,126,000,000 JPY
Other, net
0 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
1,500,000,000 JPY
851,000,000 JPY
Net increase (decrease) in cash and cash equivalents
5,052,000,000 JPY
-12,993,000,000 JPY
Cash and cash equivalents
38,223,000,000 JPY
33,171,000,000 JPY
36,065,000,000 JPY
49,058,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.